Incidence and risk factors for development of left ventricular hypertrophy in Fabry disease

Back

ESC Professional Premium Access

Incidence and risk factors for development of left ventricular hypertrophy in Fabry disease

Session: Anderson-Fabry disease: what is in store?

Topic: Hypertrophic Cardiomyopathy

Speaker: Doctor E. Monda (Naples, IT)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Emanuele Monda

University of Campania Luigi Vanvitell, Naples (Italy)

0 follower

6 more presentations in this session

Artificial intelligence (AI)-enhanced electrocardiography: a machine-learning model for differential diagnosis between hypertrophic cardiomyopathy, cardiac amyloidosis and Anderson-Fabry disease

Speaker: Doctor I. Ruotolo (Bologna, IT)

Development and validation of a smartphone based app to guide the differential diagnosis in patients with primary left ventricular hypertrophy: the Thick Heart App

Speaker: Doctor N. Maurizi (Lausanne, CH)

Anderson-Fabry disease patients with anatomical heart hypertrophy express a higher degree of electrocardiographic hypertrophy compared to hypertrophic cardiomyopathy patients

Speaker: Doctor F. Di Nicola (Bologna, IT)

Prognostic role of ECG patterns in Anderson Fabry disease.

Speaker: Doctor S. Serratore (Catanzaro, IT)

Changes in peak oxygen consumption on excercise and cardiomyopathy disease stage in Fabry disease

Speaker: Doctor A. Roy (Birmingham, GB)

Access the full session

Anderson-Fabry disease: what is in store?

Speakers: Doctor E. Monda, Doctor I. Ruotolo, Doctor N. Maurizi, Doctor F. Di Nicola, Doctor S. Serratore...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources